Care of the adult woman with Turner syndrome

References

• Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 2006;91:3897–902
   PubMed Web of Science ®Google Scholar
• Zhong Q, Layman LC. Genetic considerations in the patient with Turner syndrome–45, X with or without mosaicism. Fertil Steril 2012;98:775–9
   PubMed Web of Science ®Google Scholar
• Sybert VP, McCauley E. Turner's syndrome. N Engl J Med 2004;351:1227–38
   PubMed Web of Science ®Google Scholar
• Cameron-Pimblett A, La Rosa C, King TFJ, Davies MC, Conway GS. The Turner syndrome life course project: karyotype-phenotype analyses across the lifespan. Clin Endocrinol (Oxf) 2017;87:532–8
   PubMed Web of Science ®Google Scholar
• Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA. United Kingdom Clinical Cytogenetics Group. Mortality in women with turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab 2008;93:4735–42
   PubMed Web of Science ®Google Scholar
• Leppig KA, Sybert VP, Ross JL. Phenotype and X inactivation in 45,X/46,X,r(X) cases. Am J Med Genet A 2004;128A:276–84
   PubMed Web of Science ®Google Scholar
• Vincent A, Nguyen H, Ranasinha S, Vollenhoven B. Increased detection of co-morbidities is associated with comprehensive health screening at a dedicated multidisciplinary adult Turner Syndrome clinic. Female Reproductive Endocrinology and Female Reproductive Tract (posters). Poster FR1-162. Endocrine Rev 2016;37 Issue 2 Suppl
   Google Scholar
• Gravholt CH, Andersen NH, Conway GS. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol 2017;177:G1–70
   PubMed Web of Science ®Google Scholar
• Hook EB. Exclusion of chromosomal mosaicism: tables of 90%, 95% and 99% confidence limits and comments on use. Am J Hum Genet 1977;29:94–7
   PubMed Web of Science ®Google Scholar
• Russell LM, Strike P, Browne CE, Jacobs PA. X chromosome loss and ageing. Cytogenet Genome Res 2007;116:181–5
   PubMed Web of Science ®Google Scholar
• Lee MC, Conway GS. Turner's syndrome: challenges of late diagnosis. Lancet Diabetes Endocrinol 2014;2:333–8
   PubMed Web of Science ®Google Scholar
• Modi DN, Sane S, Bhartiya D. Accelerated germ cell apoptosis in sex chromosome aneuploid fetal human gonads. Mol Hum Reprod 2003;9:219–25
   PubMed Web of Science ®Google Scholar
• Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G. Spontaneous pubertal development in Turner’s Syndrome. J Clin Endocrinol Metab 1997;82:1810–13
   PubMed Web of Science ®Google Scholar
• Birgit B, Julius H, Carsten R. Fertility preservation in girls with turner syndrome: prognostic signs of the presence of ovarian follicles. J Clin Endocrinol Metab 2009;94:74–80
   PubMed Web of Science ®Google Scholar
• Lunding SA, Aksglaede L, Anderson RA, et al. AMH as predictor of premature ovarian insufficiency: a longitudinal study of 120 Turner syndrome patients. J Clin Endocrinol Metab 2015;100:E1030–8
   PubMed Web of Science ®Google Scholar
• Cintron D, Rodriguez-Gutierrez R, Serrano V, Latortue-Albino P, Erwin PJ, Murad MH. Effect of estrogen replacement therapy on bone and cardiovascular outcomes in women with turner syndrome: a systematic review and meta-analysis. Endocrine 2017;55:366–75
   PubMed Web of Science ®Google Scholar
• L’Hermite M. HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT. Climacteric 2013;16(Suppl):44–53
   PubMedGoogle Scholar
• Ross JL, Quigley CA, Cao D, et al. Growth hormone plus childhood low-dose estrogen in Turner's syndrome. N Engl J Med 2011;364:1230–42
   PubMed Web of Science ®Google Scholar
• Conway G, Critchley HOD, Sex steroid replacement for pubertal induction and replacement in the adolescent girl. Scientific Impact Paper 40. London, UK: Royal College of Obstetricians and Gynaecologists, 2013
   Google Scholar
• Soriano-Guillen L, Coste J, Ecosse E, et al. Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone. J Clin Endocrinol Metab 2005;90:5197–204
   PubMed Web of Science ®Google Scholar
• Bakalov VK, Shawker T, Ceniceros I, Bondy CA. Uterine development in Turner syndrome. J Pediatrics 2007;151:e1528–31
   Web of Science ®Google Scholar
• Nabhan ZM, Dimeglio LA, Qi R, Perkins SM, Eugster EA. Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study. J Clin Endocrinol Metab 2009;94:2009–14
   PubMed Web of Science ®Google Scholar
• Torres-Santiago L, Mericq V, Taboada M, et al. Metabolic effects of oral versus transdermal 17beta-estradiol (E(2)): a randomized clinical trial in girls with Turner syndrome. J Clin Endocrinol Metab 2013;98:2716–24
   PubMed Web of Science ®Google Scholar
• Ross JL, Roeltgen D, Feuillan P, Kushner H, Cutler GB. Jr, Effects of estrogen on nonverbal processing speed and motor function in girls with Turner's syndrome. J Clin Endocrinol Metab 1998;83:3198–204
   PubMed Web of Science ®Google Scholar
• Ross JL, Roeltgen D, Feuillan P, Kushner H, Cutler GB. Use of estrogen in young girls with Turner syndrome: effects on memory. Neurology 2000;54:164–70
   PubMed Web of Science ®Google Scholar
• Nguyen HH, Wong P, Strauss BJ, et al. Delay in estrogen commencement is associated with lower bone mineral density in Turner syndrome. Climacteric 2017;20:436–41
   PubMed Web of Science ®Google Scholar
• Elsheikh M, Hodgson HJF, Wass JAH, Conway GS. Hormone replacement therapy may improve hepatic function in women with Turner's syndrome. Clin Endocrinol (Oxf) 2001;55:227–31
   PubMed Web of Science ®Google Scholar
• Gravholt CH, Poulsen HE, Ott P, Christiansen JS, Vilstrup H. Quantitative liver functions in Turner syndrome with and without hormone replacement therapy. Eur J Endocrinol 2007;156:679–86
   PubMed Web of Science ®Google Scholar
• Gravholt CH, Naeraa RW, Nyholm B, et al. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Diabetes Care 1998;21:1062–70
   PubMed Web of Science ®Google Scholar
• Elsheikh M, Bird R, Casadei B, Conway GS, Wass JA. The effect of hormone replacement therapy on cardiovascular hemodynamics in women with Turner's syndrome. J Clin Endocrinol Metab 2000;85:614–18
   PubMed Web of Science ®Google Scholar
• Jospe N, Orlowski CC, Furlanetto RW. Comparison of transdermal and oral estrogen therapy in girls with Turner's syndrome. J Pediatr Endocrinol Metab 1995;8:111–16
   PubMed Web of Science ®Google Scholar
• Mauras N, Shulman D, Hsiang HY, Balagopal P, Welch S. Metabolic effects of oral versus transdermal estrogen in growth hormone-treated girls with turner syndrome. J Clin Endocrinol Metab 2007;92:4154–60
   PubMed Web of Science ®Google Scholar
• Taboada M, Santen R, Lima J, et al. Pharmacokinetics and pharmacodynamics of oral and transdermal 17beta estradiol in girls with Turner syndrome. J Clin Endocrinol Metab 2011;96:3502–10
   PubMed Web of Science ®Google Scholar
• Alves ST, Gallichio CT, Guimaraes MM. Insulin resistance and body composition in Turner syndrome: effect of sequential change in the route of estrogen administration. Gynecol Endocrinol 2006;22:590–4
   PubMed Web of Science ®Google Scholar
• Reinehr T, Lindberg A, Toschke C, Cara J, Chrysis D, Camacho-Hübner C. Weight gain in Turner Syndrome: association to puberty induction? Longitudinal analysis of KIGS data. Clin Endocrinol 2016;85:85–91
   PubMed Web of Science ®Google Scholar
• Langrish JP, Mills NL, Bath LE. Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension 2009;53:805–11
   PubMed Web of Science ®Google Scholar
• Cleemann L, Holm K, Kobbernagel H, et al. Dosage of estradiol, bone and body composition in Turner syndrome: a 5-year randomized controlled clinical trial. Eur J Endocrinol 2017;176:233–42
   PubMed Web of Science ®Google Scholar
• Baber RJ, Panay N, Fenton A. IMS Working Group. 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric 2016;19:109–50
   PubMed Web of Science ®Google Scholar
• Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA. UK Clinical Cytogenetics Group. Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study. Lancet Oncol 2008;9:239–46
   PubMed Web of Science ®Google Scholar
• Bosze P, Toth A, Torok M. Hormone replacement and the risk of breast cancer in Turner's syndrome. N Engl J Med 2006;355:2599–600
   PubMed Web of Science ®Google Scholar
• Gravholt CH, Svenstrup B, Bennett P, Sandahl Christiansen J. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status. Clin Endocrinol (Oxf) 1999;50:791–800
   PubMed Web of Science ®Google Scholar
• Carel J-C, Elie C, Ecosse E, et al. Self-esteem and social adjustment in young women with Turner syndrome–influence of pubertal management and sexuality: population-based cohort study. J Clin Endocrinol Metab 2006;91:2972–9
   PubMed Web of Science ®Google Scholar
• Zuckerman-Levin N, Frolova-Bishara T, Militianu D, Levin M, Aharon-Peretz J, Hochberg ZE. Androgen replacement therapy in Turner syndrome: a pilot study. J Clin Endocrinol Metab 2009;94:4820–7
   PubMed Web of Science ®Google Scholar
• Sutton EJ, McInerney‐Leo A, et al. Turner syndrome: four challenges across the lifespan. Am J Med Genet A 2005;139A: 57–66
   PubMed Web of Science ®Google Scholar
• Bernard V, Donadille B, Zenaty D, et al. Spontaneous fertility and pregnancy outcomes amongst 480 women with Turner syndrome. Hum Reprod 2016;31:782–8
   PubMed Web of Science ®Google Scholar
• Birkebaek NH, Cruger D, Hansen J, Nielsen J, Bruun-Petersen G. Fertility and pregnancy outcome in Danish women with Turner syndrome. Clin Genet 2002;61:35–9
   PubMed Web of Science ®Google Scholar
• Hagman A, Loft A, Wennerholm U-B, et al. Obstetric and neonatal outcome after oocyte donation in 106 women with Turner syndrome: a Nordic cohort study. Hum Reprod 2013;28:1598–609
   PubMed Web of Science ®Google Scholar
• Hadnott TN, Gould HN, Gharib AM, Bondy CA. Outcomes of spontaneous and assisted pregnancies in Turner syndrome: the U.S. National Institutes of Health experience. Fertil Steril 2011;95: 2251–6
   PubMed Web of Science ®Google Scholar
• Chevalier N, Letur H, Lelannou D, et al. French Study Group for Oocyte Donation. Materno-fetal cardiovascular complications in Turner syndrome after oocyte donation: insufficient prepregnancy screening and pregnancy follow-up are associated with poor outcome. Obstet Gynecol Surv 2011;66:275–7
   Web of Science ®Google Scholar
• Cabanes L, Chalas C, Christin-Maitre S, et al. Turner syndrome and pregnancy: clinical practice. Recommendations for the management of patients with Turner syndrome before and during pregnancy. Eur J Obstet Gynecol Reprod Biol 2010;152:18–24
   PubMed Web of Science ®Google Scholar
• Chalas Boissonnas C, Davy C, Marszalek A, et al. Cardiovascular findings in women suffering from Turner syndrome requesting oocyte donation. Hum Reprod 2011;26:2754–62
   PubMed Web of Science ®Google Scholar
• Mortensen KH, Andersen NH, Gravholt CH. Cardiovascular phenotype in Turner syndrome–integrating cardiology, genetics, and endocrinology. Endocrine Rev 2012;33:677–714
   PubMed Web of Science ®Google Scholar
• Ostberg JE, Donald AE, Halcox JP, Storry C, McCarthy C, Conway GS. Vasculopathy in Turner syndrome: arterial dilatation and intimal thickening without endothelial dysfunction. J Clin Endocrinol Metab 2005;90:5161–6
   PubMed Web of Science ®Google Scholar
• Gravholt CH, Juul S, Naeraa RW, Hansen J. Morbidity in Turner syndrome. J Clin Epidemiol 1998;51:147–58
   PubMed Web of Science ®Google Scholar
• Gravholt CH, Landin-Wilhelmsen K, Stochholm K. Clinical and epidemiological description of aortic dissection in Turner's syndrome. Cardiol Young 2006;16:430–6
   PubMed Web of Science ®Google Scholar
• Bryman I, Sylven L, Berntorp K, et al. Pregnancy rate and outcome in Swedish women with Turner syndrome. Fertil Steril 2011;95:2507–10
   PubMed Web of Science ®Google Scholar
• Carlson M, Airhart N, Lopez L, Silberbach M. Moderate aortic enlargement and bicuspid aortic valve are associated with aortic dissection in Turner syndrome: report of the International Turner Syndrome Aortic Dissection Registry. Circulation 2012;126:2220–6
   PubMed Web of Science ®Google Scholar
• Matura LA, Ho VB, Rosing DR, Bondy CA. Aortic dilatation and dissection in Turner syndrome. Circulation 2007;116:1663–70
   PubMed Web of Science ®Google Scholar
• Ostberg JE, Brookes JA, McCarthy C, Halcox J, Conway GS. A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome. J Clin Endocrinol Metab 2004;89:5966–71
   PubMed Web of Science ®Google Scholar
• De Groote K, Demulier L, De Backer J, et al. Arterial hypertension in Turner syndrome: a review of the literature and a practical approach for diagnosis and treatment. J Hypertens 2015;33: 1342–51
   PubMed Web of Science ®Google Scholar
• Turgeon JL, Carr MC, Maki PM, Mendelsohn ME, Wise PM. Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: insights from basic science and clinical studies. Endocr Rev 2006;27:575–605
   PubMed Web of Science ®Google Scholar
• Gravholt CH, Vestergaard P, Hermann AP, Mosekilde L, Brixen K, Christiansen JS. Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey. Clin Endocrinol (Oxf) 2003;59:89–96
   PubMed Web of Science ®Google Scholar
• Ross JL, Long LM, Feuillan P, Cassorla F, Cutler GB. Jr. Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome. J Clin Endocrinol Metab 1991;73:355–9
   PubMed Web of Science ®Google Scholar
• Landin-Wilhelmsen K, Bryman I, Windh M, Wilhelmsen L. Osteoporosis and fractures in Turner syndrome-importance of growth promoting and oestrogen therapy. Clin Endocrinol (Oxf) 1999;51:497–502
   PubMed Web of Science ®Google Scholar
• Wasserman H, Backeljauw PF, Khoury JC, Kalkwarf HJ, Gordon CM. Bone fragility in Turner syndrome: fracture prevalence and risk factors determined by a national patient survey. Clin Endocrinol (Oxf) 2018;89:46–55
   PubMed Web of Science ®Google Scholar
• Bakalov VK, Bondy CA. Fracture risk and bone mineral density in Turner syndrome. Rev Endocr Metab Disord 2008;9:145–51
   PubMed Web of Science ®Google Scholar
• Han TS, Cadge B, Conway GS. Hearing impairment and low bone mineral density increase the risk of bone fractures in women with Turner's syndrome. Clin Endocrinol 2006;65:643–7
   PubMed Web of Science ®Google Scholar
• Vincent AJ, Nguyen HH, Ranasinha S, Vollenhoven B. Increased detection of co-morbidities with evaluation at a dedicated adult Turner syndrome clinic. Climacteric 2017;20:442–7
   PubMed Web of Science ®Google Scholar
• Freriks K, Timmermans J, Beerendonk CC, et al. Standardized multidisciplinary evaluation yields significant previously undiagnosed morbidity in adult women with Turner syndrome. J Clin Endocrinol Metab 2011;96:E1517–26
   PubMed Web of Science ®Google Scholar
• Manolagas SC, O'Brien CA, Almeida M. The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol 2013;9:699–712
   PubMed Web of Science ®Google Scholar
• Soucek O, Schonau E, Lebl J, Willnecker J, Hlavka Z, Sumnik Z. A 6-year follow-up of fracture incidence and volumetric bone mineral density development in girls with Turner syndrome. J Clin Endocrinol Metab 2018;103:1188–97
   PubMed Web of Science ®Google Scholar
• Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, et al. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study. Pediatr Res 2001;50:417–22
   PubMed Web of Science ®Google Scholar
• Bertelloni S, Cinquanta L, Baroncelli GI, Simi P, Rossi S, Saggese G. Volumetric bone mineral density in young women with Turner's syndrome treated with estrogens or estrogens plus growth hormone. Horm Res 2000;53:72–6
   PubMedGoogle Scholar
• Nadeem M, Roche EF. Bone mineral density in Turner's syndrome and the influence of pubertal development. Acta Paediatr 2014;103:e38–42
   PubMed Web of Science ®Google Scholar
• Hogler W, Briody J, Moore B, Garnett S, Lu PW, Cowell CT. Importance of estrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry. J Clin Endocrinol Metab 2004;89:193–9
   PubMed Web of Science ®Google Scholar
• Suganuma N, Furuhashi M, Hirooka T, et al. Bone mineral density in adult patients with Turner's syndrome: analyses of the effectiveness of GH and ovarian steroid hormone replacement therapies. Endocr J 2003;50:263–9
   PubMed Web of Science ®Google Scholar
• Prentice A, Parsons TJ, Cole TJ. Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants. Am J Clin Nutr 1994;60:837–42
   PubMed Web of Science ®Google Scholar
• Holroyd CR, Davies JH, Taylor P, et al. Reduced cortical bone density with normal trabecular bone density in girls with Turner syndrome. Osteoporos Int 2010;21:2093–9
   PubMed Web of Science ®Google Scholar
• Shaw NJ, Rehan VK, Husain S, Marshall T, Smith CS. Bone mineral density in Turner's syndrome–a longitudinal study. Clin Endocrinol (Oxf) 1997;47:367–70
   PubMed Web of Science ®Google Scholar
• Bechtold S, Rauch F, Noelle V, et al. Musculoskeletal analyses of the forearm in young women with Turner syndrome: a study using peripheral quantitative computed tomography. J Clin Endocrinol Metab 2001;86:5819–23
   PubMed Web of Science ®Google Scholar
• Soucek O, Lebl J, Snajderova M, et al. Bone geometry and volumetric bone mineral density in girls with Turner syndrome of different pubertal stages. Clin Endocrinol (Oxf) 2011;74: 445–52
   PubMed Web of Science ®Google Scholar
• Soucek O, Zapletalova J, Zemkova D, et al. Prepubertal girls with Turner syndrome and children with isolated SHOX deficiency have similar bone geometry at the radius. J Clin Endocrinol Metab 2013;98:E1241–7
   PubMed Web of Science ®Google Scholar
• Hansen S, Brixen K, Gravholt CH. Compromised trabecular microarchitecture and lower finite element estimates of radius and tibia bone strength in adults with turner syndrome: a cross-sectional study using high-resolution-pQCT. J Bone Miner Res 2012;27:1794–803
   PubMed Web of Science ®Google Scholar
• Naess EE, Bahr D, Gravholt CH. Health status in women with Turner syndrome: a questionnaire study on health status, education, work participation and aspects of sexual functioning. Clin Endocrinol 2010;72:678–84
   PubMed Web of Science ®Google Scholar